Browsing by Author Haferkamp, Sebastian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2012Absence of Distinguishing Senescence Traits in Human Melanocytic NeviBecker, Therese; Gowrishankar, Kavitha; Kefford, Richard (Rick); Rizos, Helen; Scolyer, Richard; Scurr, Lyndee; Thompson, John; Tran, Sieu; Desilva, Chitra; Haferkamp, Sebastian; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead); Central Clinical School: Surgery; Western Clinical School: Medicine (Westmead)Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi, The Journal of Investigative Dermatology, vol.132, 9, 2012,pp 2226-2234
2009The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4aBecker, Therese; Diefenbach, Eve; Dijkstra, Menno; Frausto, Monika; Haferkamp, Sebastian; Kefford, Richard (Rick); Mann, Graham; Rizos, Helen; Scolyer, Richard; Scurr, Lyndee; Reisman, David N.; Western Clinical School: Westmead Millennium Institute; Sydnovate; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a, Molecular Cancer, vol.8,(4),2009,pp 4-1-4-12
2010IGFBP7 is not required for B-RAF-induced melanocyte senescenceBecker, Therese; Haferkamp, Sebastian; Irvine, Malama; Kefford, Richard (Rick); Mann, Graham; Pupo, Gulietta; Rizos, Helen; Scolyer, Richard; Scurr, Lyndee; Becker, Jurgen; Lai, Ken; Schrama, David; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)IGFBP7 is not required for B-RAF-induced melanocyte senescence, Cell, vol.141, 4,pp 717-727
2011Merkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell CarcinomaScolyer, Richard; Thompson, John; Becker, Jurgen; Eib, Steffi; Haferkamp, Sebastian; Houben, Roland; Kneitz, Hermann; Moore, Patrick; Peitsch, Wiebke; Pfohler, Claudia; Schrama, David; Shuda, Masahiro; Trefzer, Uwe; Zapatka, Marc; Central Clinical School: Pathology; Central Clinical School: SurgeryMerkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma, The Journal of Investigative Dermatology, vol.131, 8, 2011,pp 1631-1638
2013Molecular Mechanisms of Cellular SenescenceBecker, Therese; Haferkamp, Sebastian; Western Clinical School: Westmead Millennium InstituteMolecular Mechanisms of Cellular Senescence in Senescence and Senescence-related disorders, InTech Open Access Publishers (peer reviewed), 2013, pp. 25-50
2009Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor SuppressorsBecker, Therese; Frausto, Monika; Haferkamp, Sebastian; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor Suppressors, The Journal of Investigative Dermatology, vol.129, 8, 2009,pp 1983-1991
2008p16(INK4a)-induced senescence is disabled by melanoma-associated mutationsBecker, Therese; Haferkamp, Sebastian; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)p16(INK4a)-induced senescence is disabled by melanoma-associated mutations, Aging Cell, vol.7, 5, 2008,pp 733-745
2009The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescenceBecker, Therese; Haferkamp, Sebastian; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Tran, Sieu; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence, Aging, vol.1, 6,pp 542-556
2013Vemurafenib induces senescence features in melanoma cellsBecker, Therese; Adam, Christian; Borst, Andreas; Haferkamp, Sebastian; Houben, Roland; Hufnagel, Anita; Meierjohann, Svenja; Motschenbacher, Stephanie; Windhovel, Simone; Western Clinical School: Westmead Millennium InstituteVemurafenib induces senescence features in melanoma cells, The Journal of Investigative Dermatology, vol.133, 6, 2013,pp 1601-1609